Confronting the drug safety debate head-on, Pfizer will advertise its pain pill Celebrex to consumers for the first time in two years. The medicine, along with rival Vioxx from Merck , became a ...

with the correct structure for Celebrex. Weeks before a scheduled trial, Pfizer and Brigham Young University have settled a six-year-old lawsuit brought by the university and Daniel L. Simmons ...

Pfizer has revived TV advertising for its arthritis painkiller Celebrex with a bracing animated spot (pictured at left) that hammers away at problems with alternative pills, such as prescription ...

(CBS4) - A new study gives a cleaner bill of health to the anti-arthritis pill Celebrex, a drug that's supposed to be easier on your stomach than other pain medications. Yet with it a comes with a ...

A US district court has invalidated a patent (US RE 44048) that describes methods of using Celebrex (celecoxib) to treat inflammatory disorders. This means that patent protection for the ...

A competitor made by Pfizer, Bextra, was yanked some months later, leaving only Pfizer’s Celebrex behind—and a new, required safety warning hasn’t exactly done wonders for that drug’s appeal.

Now the results are in. Sixty-four-year-old Mary Kay Bossard, a respiratory therapist, takes Celebrex to relieve debilitating pain from arthritis. “It’s my hands, it’s my shoulders,” she said.

Sept. 12, 2006 — -- The painkiller Celebrex may be safe for some patients who suffer from chronic bone and joint pain, even though similar drugs come with dangerous side effects, according to ...

The comeback continues for Pfizer's Celebrex, baby step by baby step. In the latest turn, Pfizer may resume TV advertising for Celebrex, three years after the company pulled the ads in the wake of ...